1. New TAVI Platform Adds More Valve Sizes to Choose From.
- Author
-
Bosworth, Ted
- Subjects
- *
VALVES , *HEART valve prosthesis implantation - Abstract
A recent international randomized trial compared the safety and efficacy of intermediate valve sizes for transcatheter aortic valve implantation (TAVI) with standard sizes. The trial found that the new Myval platform, which offers multiple valves sized at 1.5 mm intervals, was at least as safe and effective as the balloon-expandable Sapien valve from Edwards Lifesciences and the self-expanding Evolut valve from Medtronic. The study enrolled 768 patients and found that the Myval platform provided a numerical advantage in both safety and efficacy. However, longer-term follow-up is needed to determine the impact on patient prognosis and valve durability. [Extracted from the article]
- Published
- 2024